CAR T cell therapy is a form of immunotherapy that harnesses the body's immune system to fight cancer. T cells are collected from a patient and genetically engineered to produce receptors on their surface called chimeric antigen receptors (CARs). These receptors are designed to recognize and bind to specific proteins on the surface of cancer cells. Once administered back into the patient, these modified T cells can seek and destroy cancer cells more effectively.
